Literature DB >> 35136822

Yoga for COVID - 19.

Nupur B Patel1, Itish Patnaik2.   

Abstract

Entities:  

Year:  2021        PMID: 35136822      PMCID: PMC8797117          DOI: 10.4103/jfmpc.jfmpc_1837_21

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


× No keyword cloud information.
Yoga deals with the holistic principle of connecting the body, mind, and consciousness. Ancient Indian books like Vedas and Puranas have mentioned the healing properties of yoga. It has shown improvement in people with post-traumatic stress disorder, reducing fatigue in cancer patients, reducing blood pressure in hypertensives, reducing sugar in diabetic patients, and symptoms of menopause.[1] Several clinical trials have shown the effect of yoga in improvement in pulmonary function tests in asthma and chronic obstructive pulmonary disease.[2] There are reports of achieving earlier sputum negativity in tuberculosis patients and an increase in CD-4 cell count in HIV patients by integrative yoga.[2] The three pillars of yoga are asana (body postures), pranayama (breathing exercise), and meditation with or without chanting mantras. It can reduce the fight or flight response of stress by increasing the vagal stimulation. Its anti-inflammatory activity includes reduction in natural killer (NK) cell, C-reactive protein (CRP), and T-cell cytokine (IL-12, IL-6), and an increase in anti-inflammatory cytokine (IL-10).[3] Studies have shown that yoga may enhance the production and activity of melatonin, hormone-possessing antiviral, immune-enhancing, and anti-inflammatory property. COVID-19 is among the most extreme stressors possible to be experienced not only by the patient, but also by the family members and healthcare workers. Psychosocial stress can reduce immunity against infectious challenges and overstimulate host inflammatory responses, leading to tissue damage and even death. COVID-19 is associated with an increase in inflammatory markers (IL-6, CRP, ferritin, etc.). Yoga can reduce mental stress and anxiety in asymptomatic COVID-19 patients during home isolation or postrecovery and reduce burnout syndrome in healthcare workers.[4] It can also be used as a therapy in symptomatic patients with mild to moderate acute respiratory distress syndrome (ARDS) on face mask, high-flow oxygen cannula, or non-invasive mechanical ventilation. Various asanas and pranayama can be taught to patients virtually by telemedicine through computers, mobile phones, or tablets. However, clinical trials can prove the therapeutic role of yoga in COVID-19 patients with mild to moderate ARDS.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Meditation and Yoga Practices as Potential Adjunctive Treatment of SARS-CoV-2 Infection and COVID-19: A Brief Overview of Key Subjects.

Authors:  William Bushell; Ryan Castle; Michelle A Williams; Kimberly C Brouwer; Rudolph E Tanzi; Deepak Chopra; Paul J Mills
Journal:  J Altern Complement Med       Date:  2020-06-22       Impact factor: 2.579

2.  Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial.

Authors:  Ka Sing Paris Lai; Christine Watt; Emily Ionson; Imants Baruss; Cheryl Forchuk; Javeed Sukhera; Amer M Burhan; Akshya Vasudev
Journal:  Trials       Date:  2020-07-14       Impact factor: 2.279

3.  Yoga for COVID-19 and natural disaster related mental health issues: Challenges and perspectives.

Authors:  Ramdas Ransing; Mariana Pinto da Costa; Frances Adiukwu; Paolo Grandinetti; Andre Luiz Schuh Teixeira; Ozge Kilic; Joan Soler-Vidal; Rodrigo Ramalho
Journal:  Asian J Psychiatr       Date:  2020-08-27
  4 in total
  1 in total

1.  Impact of Yoga Practice on Level of Stress During COVID-19 Pandemic.

Authors:  Selma Sinanovic; Ana Vidacek; Mirsad Muftic
Journal:  Mater Sociomed       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.